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Abstract Based on a twelve residue master peptide comprising
all five specific cleavage sites defined for the proteasome, a set of
variant peptides was generated in order to probe specificity and
to elucidate the mechanism which determines product size. It is
shown that the rate of degradation by the 20S proteasome from
Thermoplasma acidophilum depends critically on the length of
the peptide substrate. Peptides of 14 residues and longer are
degraded much faster than shorter peptides although the sites of
cleavage remain unchanged. The decelerated degradation of
peptides shorter than 14 residues explains the accumulation of
products with an average length of seven to nine residues.
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1. Introduction
Self-compartmentalization has begun to emerge as a regu-
latory principle common to several proteolytic enzymes (for
recent reviews see [1,2]). The proteasome became the para-
digm of a class of proteases unrelated in sequence and fold
which have converged towards a common architecture: the
rather large homo- or heterooligomeric assemblies enclose in-
ner cavities, several nanometers in size, which allow them to
con¢ne the proteolytic action. Access to these nanocompart-
ments is restricted to unfolded polypeptides which can pass
through the narrow gates guarding the entrance. Therefore,
these proteases must interact with a machinery capable of
recognizing target proteins and rendering them degradable,
i.e. presenting them in an unfolded form to the protease. In
eukaryotic proteasomes these functions are provided by the
19S cap complexes which associate with the 20S proteolytic
core complex to form the 26S proteasome. Related but much
simpler precursor complexes were recently described for bac-
teria [3] and archaea (Zwickl, P., personal communication).
The 20S complex is a barrel-shaped structure of four stacked
rings. Each outer ring contains either seven identical (bacteria,
archaea) or seven distinct but related (eukaryotes) K-type sub-
units; the two adjacent inner rings contain seven identical or
related L-type subunits. Jointly, the two L-rings form the cen-
tral cavity from where the active sites are accessible. Protea-
somes degrade substrates by a novel catalytic mechanism, in
which the hydroxyl group of the N-terminal threonine of a
L-type subunit serves as the active site nucleophile [4,5]. While
in archaeal and bacterial proteasomes all 14 L-type subunits
are proteolytically active, in eukaryotic proteasomes only 6 of
the 14 L-type subunits have an N-terminal threonine and thus
contribute to the proteolytic activity. In order to access the
proteolytic central cavity of the 20S complex substrate pro-
teins must pass the narrow constrictions, an outer one formed
by the K-subunit ring and an inner one formed by the L-sub-
unit ring. Beyond allowing to control proteolysis, the con¢ne-
ment of the proteolytic action to the central cavity also pro-
vides the basis for the proteasome’s processive mode of
action: it does not release peptides after a single cleavage
but proceeds to make multiple cleavages before discharging
the degradation products [6,7]. When the speci¢city of protea-
somes is probed with short £uorogenic peptides three major
peptidase activities are found in eukaryotic 20S proteasomes:
a chymotrypsin-like (P1 residue in substrate is hydrophobic or
aromatic amino acid), a trypsin-like (P1 is basic amino acid)
and a peptidylglutamyl-peptide hydrolyzing (P1 is glutamate)
activity. Additionally, a branched-chain amino acid preferring
and a small neutral amino acid preferring activity have been
de¢ned [8]. With the same type of assay, archaeal and bacte-
rial proteasomes exhibit only chymotrypsin-like activity [9,10].
However, when longer peptides or proteins are used as sub-
strates the very complex cleavage patterns do not correlate
with the aforementioned speci¢cities [11,12]. Obviously an as-
signment of speci¢cities using the residue directly adjacent to
the cleavage site (the P1 position) falls short of reality. Recent
studies, using irreversible inhibitors of proteasome activity
indicate that the P4 position has a critical role in de¢ning
speci¢city [13].
It is intriguing to observe that, in spite of cleaving protein
substrates in an apparently non-speci¢c manner, the peptide
products fall into a relatively narrow size range, averaging
around 7^9 residues. It is this feature, which predisposed
the proteasome for a role it assumed in the course of evolu-
tion, namely the generation of immunocompetent peptides
[14^16]. The observation that peptide products have a re-
stricted range of sizes led to the proposal that proteasomes
may possess an intrinsic molecular ruler. One of the options
considered at the time was that the distance between active
sites, acting in concert, could provide the mechanistic basis for
such a ruler [11]. When the crystal structure of the Thermo-
plasma proteasome revealed a distance of 2.8 nm between
neighboring active sites, which corresponds to a hepta- or
octapeptide in an extended conformation, this seemed to pro-
vide strong evidence in support of such a molecular ruler
hypothesis [4]. On the other hand, recent more quantitative
analyses of product length, while in agreement with an aver-
age length of 8 þ 1 residues, showed larger size variations,
which are di⁄cult to reconcile with a purely geometry-based
ruler which should yield products more focused in length [17].
In this communication we report on degradation experi-
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ments performed with Thermoplasma proteasomes and a set
of synthetic peptide substrates which were designed to identify
features which (co)determine cleavage sites and product size.
To this end we have chosen a master peptide of 12 residues
(Fig. 1) which contains all ¢ve of the aforementioned speci¢c
cleavage sites de¢ned for proteasomes at least once. This pep-
tide is derived from the human hemoglobin A chain and in-
cludes residues 23^31. We have mutated and permutated this
sequence and extended it in length up to 23 residues by (par-
tial) sequence duplication; thus while changing the length of
the peptide, the cleavage sites remain the same (Fig. 2). Sur-
prisingly, it turns out that the rate of degradation depends
critically on the length of the substrate peptides.
2. Materials and methods
2.1. Materials
BL21(DE3) cells were obtained from Stratagene (Germany) and Ni-
NTA resin from Qiagen (Germany), and oxidized insulin L-chain was
from Sigma (Germany). Peptides were synthesized on a multiple pep-
tide synthesizer (MultiSynTech) by conventional £uorenylmethyloxy-
carbonyl chemistry and the purity was determined by reverse phase
HPLC. All other chemicals were of analytical grade.
2.2. Expression and puri¢cation of recombinant Thermoplasma
proteasomes
BL21(DE3) cells were transformed with plasmid pRSET5a, con-
taining the genes for the wild-type K-subunit and L-subunit of the
Thermoplasma acidophilum proteasome with a His6-tag at the C-ter-
minus of the L-subunit. Cells were grown in SOB medium to mid-log
phase at 37‡C. Five hours after induction with 1 mM IPTG cells were
harvested, suspended in sonication bu¡er (50 mM Na-phosphate, 300
mM NaCl, pH 8.0), and sonicated for 10 min (Soni¢er 250, Branson).
The lysate was centrifuged (30 000Ug, 1 h), and the supernatant was
applied to a Ni-NTA a⁄nity column (0.65U4 cm), equilibrated in
sonication bu¡er. Unbound proteins were removed with wash bu¡er
(50 mM Na-phosphate, 300 mM NaCl, pH 6.0) and His6-tagged pro-
teasomes were eluted with a gradient of 0^500 mM imidazole in wash
bu¡er. Fractions containing pure protein were pooled and dialyzed
against 50 mM Tris-HCl bu¡er with 1 mM EDTA, pH 7.5. The
enzyme was stored at 4‡C.
2.3. Hydrolysis of substrates and analysis of products
Degradation experiments with single peptide substrate or a mixture
of di¡erent peptide substrates were performed in 100 mM Tris-HCl
bu¡er with 1 mM EDTA, pH 7.5. The reaction volume was kept at
200 Wl, with a ¢nal substrate concentration of 200^400 WM, except in
determination of kcat/KM where the concentration was 50 WM. The
mixture was preheated to 60‡C before initiation of the reaction by
addition of 10 Wg recombinant proteasomes. At various time points
10-Wl aliquots were removed and the reaction was stopped with 110 Wl
0.03% tri£uoroacetic acid and the sample stored at 320‡C. The con-
sumption of substrates was observed by application of samples to an
RP-HPLC column.
Products of peptide hydrolysis were analyzed by HPLC (Gold Sys-
tem; Beckman) containing the programmable solvent module 125 and
a diode array detector module 168. For peptide separation, a 2-mm
column (C18, LiChroCart 125-2) from Merck (Germany) was used.
The column was equilibrated in 0.1% (v/v) tri£uoroacetic acid in
water. Peptides were eluted from the RP column with a linear gradient
of 0^60% acetonitrile in 0.1% tri£uoroacetic acid at a £ow rate of 0.3
ml/min over a 60-min period. Absorption of the eluted peptides was
monitored at 206 nm and at 280 nm. Fractions coinciding with ab-
sorption maxima were manually collected, concentrated by evapora-
tion and analyzed by Edman degradation on a gas-phase sequencer
477A equiped with PTH-analyzer 120A (both Applied Biosystems)
and/or by mass spectrometry. Masses were determined with a tandem
quadrupole instrument API III equipped with an atmospheric pres-
sure ionization source (Sciex, Thornhill, Ont., Canada). The instru-
ment m/z scale was calibrated with ammonium adduct ions of poly-
propylene glycol.
2.4. Determination of kcat /KM
Kinetic data for substrate hydrolysis were determined from sub-
strate consumption derived from HPLC chromatograms. kcat/KM
was calculated from the velocity relationship v=kcat/KM[Eo][S] (work-
ing at low substrate concentration), where [Eo] represents the total
enzyme concentration and [S] the substrate concentration. For kcat/
KM determination only measurements were used, where maximally
20% of substrate was consumed.
3. Results
As shown in Fig. 1 the 12-residue peptide HEYGAEALER-
AG (P12a) contains all ¢ve cleavage sites de¢ned for eukary-
otic proteasomes including a ‘chymotryptic’ site (Y3-G4),
which according to assays with £uorogenic peptides is the
preferred cleavage site for archaeal and bacterial proteasomes.
With this peptide we have performed degradation experiments
as described in Section 2; at several time points the formation
of degradation products was monitored by reversed phase
HPLC (Fig. 3). When approximately 50% of the peptides
were consumed (t1=2) the products were analyzed by mass
spectrometry and, when necessary for an unambiguous iden-
ti¢cation, also by N-terminal sequencing. Degradation of pep-
tide P12a yielded two predominant products, HEYGA and
EALERAG, implying that the bond between A5 and E6 is
the preferred cleavage site. In addition, two minor cleavage
sites have been identi¢ed between A7 and L8 and between
R10 and A11, respectively. From the estimated ratio
100:10:1 for cleavages of (A5-E6)/(A7-L8)/(R10-A11), the
dominance of the A5-E6 cleavage site is obvious. Thus the
principal cleavage site corresponds neither to the ‘chymotryp-
tic’ nor to any of the other four cleavage sites described for
proteasomes. To ¢nd out whether the preference for the A5-
E6 site is due to the alanine at position P1, this residue was
replaced by aspartic acid in peptide P12b (Fig. 2). This sub-
stitution in fact rendered the peptide resistant to degradation,
while exchange of the residue in the P1P position (E to L) had
no e¡ect at all, i.e. e⁄cient cleavage occurred between A5 and
L6 (peptide P12c) (Fig. 3B,C). This is important because the
sequon AL when occurring in a di¡erent context (for example
in the same peptide (A7-L8)) or in the insulin L-chain (see
below) is not a major cleavage site. When put into a com-
pletely di¡erent context, such as peptides IQVYSRH-
PAENGK or IEKELRHGKSAEAT the sequon AE is not
used at all as a cleavage site (data not shown). Obviously
the P1 and P1P positions are insu⁄cient as determinants of
cleavage sites. In order to examine whether the location of
sequon AE within the peptide had an e¡ect, peptides P12d
FEBS 20772 3-9-98
Fig. 1. Master peptide of 12 residues. The sequence is derived from
the human hemoglobin A chain and contains all ¢ve of the speci¢c
cleavage sites de¢ned for proteasomes.
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and P12e (Fig. 2) were designed in which this sequon is shifted
towards the C-terminus. The HPLC chromatograms show
that the changed location of AE within the peptide had no
e¡ect on its preferred cleavage (Fig. 3D,E).
For a geometry-based molecular ruler one would predict
that distance is a more important criterion for selection of a
cleavage site than sequence. We have therefore extended the
length of the master peptide P12a N-terminally. A phenylala-
nine was inserted into the 31 position to facilitate the identi-
¢cation of products; otherwise we have repeated sequence
motifs from the master peptide in order to keep potential
cleavage sites and their context unchanged. In the longest
peptide P23 the core motif EYGAEALER occurs therefore
twice in a tandem arrangement (Fig. 2). Degradation of P23
yielded three major products (Fig. 3F) and their analysis re-
vealed that the preferred cleavage sites correspond to those
identi¢ed previously in peptide P12a, i.e. irrespective of the
location in the peptide the two AE sequons are the principal
cleavage sites. Also in peptides P14 and P16 with shorter N-
terminal extensions AE remains the principal cleavage site.
The insulin L-chain has been used as a model substrate
previously with Thermoplasma [11] as well as with eukaryotic
proteasomes [12]. In most of these studies the degradation was
allowed to proceed over rather long periods of time in order
to characterize the end products. In the context of this study
we were interested in determining the preferred cleavage sites.
Degradation products of insulin L-chain at t1=2 are shown in
Fig. 2. The dominant cleavage sites are between G8 and S9,
between E13 and A14 and between V18 and C19. Minor sites
are between A14 and L15, between L17 and V18, between F24
and F25 and between F25 and Y26.
When monitoring degradation of the aforementioned sub-
strates in a time-dependent manner by reverse phase HPLC
we observed that the longer substrates were degraded more
rapidly than the shorter ones. To obtain more quantitative
insight into this phenomenon we determined apparent second
order rate constants kcat/KM for each of the substrates (Table
1). A comparison of the kcat/KM values shows a large di¡er-
ence between the shortest peptide P12a and the other peptides.
The value of approx. 350 M31 s31 for peptide P12a is almost
20 times lower than for peptide P14 which is two residues
longer, although the cleavage sites are unchanged. Interest-
ingly, it is in the same range as the values typically found
with short £uorogenic peptides such as Suc-LLVY-AMC
which are commonly used for assaying proteasome activity
(see e.g. [9]). When increasing the length of the substrates
further (14^23 residues) a marginal decrease of velocity is
observed. The rate constant for the degradation of the oxi-
dized insulin L-chain is approx. 25 000 M31 s31, i.e. this sub-
strate is degraded about 70 times faster than P12a and about
4 times faster than the P14^P23 group of substrates. From the
ratios of kcat/KM one would predict a competition between
substrates di¡ering in length, in which the longer ones are
degraded preferentially.
To test this prediction experimentally, we performed com-
petition experiments with two or three di¡erent substrates
(Fig. 4). As shown in the time-dependent elution patterns it
is indeed always the longer peptide which is degraded prefer-
entially when equimolar mixtures of peptides are exposed to
the proteasome. When P12a and P23 are mixed, P23 is de-
graded much faster than P12a (Fig. 4A). Addition of another
longer peptide (insulin L-chain at the same molar concentra-
tion) changes the order of degradation: now the insulin
L-chain is the fastest to be degraded, followed by degradation
of P23; the concentration of the shortest substrate (P12a)
remains almost unchanged during the experiment (Fig. 4B).
Repeating the experiment in the absence of the shortest pep-
tide (P12a) did not result in changes in the rate of insulin
L-chain degradation (Fig. 4C).
4. Discussion
It is obvious from the experiments reported in this commu-
nication that the Thermoplasma proteasome cleaves peptide
substrates in a speci¢c manner. In the master peptide P12a,
which contains all ¢ve cleavage sites de¢ned for proteasome, it
is surprisingly the bond between A5 and E6 which is cleaved
preferentially, and not the ‘chymotryptic’ site Y3-G4, as one
might expect from assays with short £uorogenic peptides [9].
The sequon AE remains the preferred cleavage site when it is
moved towards the C-terminus or when it occurs twice in a
23-residue peptide in which the core of the master peptide is
tandemly arranged. However, when placed in a di¡erent con-
text, such as the peptides IQVYSRHPAENGK or IE-
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Table 1
kcat/KM values for degradation of peptide substrates of di¡erent
length by the proteasome from Thermoplasma acidophilum
Substrate kcat/KM (M31 s31)
Insulin L-chain 25 000
P23 5500
P16 6000
P14 6500
P12a 350
Fig. 2. The set of peptides used in degradation experiments. The
master peptide P12a was modi¢ed as indicated by boxes. Cleavages
obtained by proteasome degradation are marked by arrows. Minor
cleavage sites in oxidized insulin L-chain are marked by small ar-
rows.
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KELRHGKSAEAT the sequon AE is no longer a cleavage
site. Some changes of residues next to the scissile bond are
tolerated; for example when AE is changed to AL (P12c),
without otherwise changing the context A5L6 remains the
dominant cleavage site. Again, when the sequon AL is placed
in a di¡erent context (A7L8 in the same peptide or in insulin
L-chain) it is no longer a preferred cleavage site. Other
changes, such as the replacement of the alanine (A5) by an
aspartic acid residue renders the peptide undegradable. We
conclude that both the residues next to the scissile bond and
their wider context determine whether or not a site is disposed
to cleavage. Given the limited set of peptides used in this
study it is clearly not feasible to unravel the non-trivial rules
which determine the proteasome speci¢city.
Surprisingly, the rate of degradation depends critically on
the length of the peptide substrate. When peptides displaying
the same array of cleavage sites are extended in the length, the
kcat/KM values change signi¢cantly. The Thermoplasma pro-
teasome is a rather slow enzyme for peptides of 12 residues
and shorter with kcat/KM values of approx. 350 M31 s31. kcat/
KM values in the same range are measured with short £uoro-
genic peptides. Peptides of 14 residues and longer are de-
graded 20 times faster although the sites of cleavage remain
unchanged. The 30-residue insulin L-chain is degraded ap-
prox. 70 times faster than the 12-mer. Consequently, one
would expect that in a competition experiment in which pep-
tides of di¡erent lengths are exposed to the proteasome, the
longer peptides are degraded before the shortest ones. This is
exactly what we observed experimentally (see Fig. 4).
It is well established now that the 20S proteasome is a
processive enzyme, i.e. a polypeptide chain which enters the
central proteolytic cavity undergoes multiple cleavages before
the degradation products are released [6,7]. It is interesting to
note that the vast majority (V95%) of the peptides which exit
the proteasome is 14 residues and shorter (see ¢gure 7 in [17]).
The average length of peptides was found to be 8 þ 1 residues.
FEBS 20772 3-9-98
Fig. 3. RP-HPLC elution chromatograms of cleavage products produced by the proteasome at half time of substrate consumption. Substrates
are described in Fig. 2. Conditions for degradations are described in Section 2.
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The upper limit in product length of the residues coincides
with the sharp drop in the velocity of degradation which we
observed for peptides shorter than 14 residues. We conclude
that these peptides are not e⁄ciently withheld by the protea-
some and have a high probability to exit ; this is equivalent to
a low a⁄nity for peptides 6 14 residues. Upon prolonged
incubation they have a chance to re-enter, but this is an in-
e⁄cient and therefore a slow process.
These considerations have consequences for the concept of
the ‘molecular ruler’. Although the mean length of the peptide
products (8 þ 1 residues) corresponds to the distance between
active sites in the Thermoplasma proteasome (2.8 nm) ^ as-
suming that peptides are in extended conformation ^ this
seems to be merely coincidental. In fact, a purely geometry-
based ruler should yield products more focused in length than
is observed experimentally [11], and distance should be the
primary determinant of a cleavage site rather than speci¢c
sequons. However, this is not what we ¢nd. For example
the sequon AE embedded in a speci¢c context remains the
cleavage site irrespective of its location in the peptide. If it
occurs twice in a peptide (P23) with an intervening sequence
of 11 residues it will remain the preferred cleavage site. An-
other indication that the distance between two subunits is not
the basis for a molecular ruler is noticed from digestion ex-
periments using proteasomes with decreased numbers of ac-
tive subunits. Cleavage sites of substrates are found to be the
same as with wild-type proteasome (Dolenc, in preparation).
Thus the proteasome cleaves polypeptides speci¢cally, but the
rules remain to be elucidated. Below a certain length (6 14
residues) degradation products have a high probability to exit
the proteasome. Although they might re-enter and be de-
graded further, this will be a slow and ine⁄cient process
and therefore degradation products 6 14 residues will accu-
mulate. It appears that the length distribution of the peptides
is kinetically or thermodynamically controlled. It should be
mentioned here that the lower ‘a⁄nity’ of the proteasome for
shorter peptides was considered as an alternative explanation
when the molecular ruler hypothesis was originally proposed
[11].
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Fig. 4. Time dependent RP-HPLC elution pro¢les for competition
experiments. The chromatogram represents the action of proteasome
in the mixture of substrates: (A) P12 and P23, (B) P12, P23 and
oxidized insulin L-chain, (C) P23 and oxidized insulin L-chain. Sub-
strates are as follows: circle represents P12; square represents P23;
cross represents oxidized insulin L-chain.
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